Tempus is the realization of one of Eric Lefkofsky’s vision to create better treatments for cancer patients around the world. Tempus was co-founded by Eric Lefkofsky and his friend Brad Keywell and it will utilize the latest technology in analytics to gather medical data. Eric’s latest efforts in fundraising amounted to more than 70 million dollars for the Chicago based company, contributing to the total of 130 million dollars raised today. Several organizations, including NEA and Revolution Growth, have funded the project as well.
Eric Lefkofsky got the idea for Tempus when he saw the effects of cancer up close and personal. Ever since then he has had the desire to improve the treatment available to cancer patients. The lack of healthcare data and virtually no technological support was surprised to Eric, but this was perfect for Eric’s background in technology. Today, he can use his wealth, business capabilities, and technological insight to create better solutions for patients looking for cancer treatment.
The majority of information in the medical field is largely disorganized and Eric realized this. With the help of Tempus, Eric believes he will be able to change the way the healthcare system operates and organizes their data in the future. Instead of losing data or being unable to find more data, Tempus will compile all healthcare data into a single database that doctors can use to create more personalized cancer treatment for patients.
Eric Lefkofsky’s Tempus solution will help aid not only cancer patients looking for more precise treatments but also individuals looking for healthcare around the world. As the largest database of medical data compiling all forms of genomic and molecular data, doctors will have an efficient and organized platform to research and pull information from. According to Eric, Tempus will enable more precise medicine that is data enabled.